A century of research.
A single field.

The BrainCode® Integrated Device introduces the corrective signal into the perineural semiconducting system that Szent-Györgyi identified as the organising substrate of physiology.

The BrainCode® Integrated Device works on the same perineural semiconducting system. Bioenergetic testing reads the DC currents Becker measured.

The EMF category among the BrainCode® frequency vectors comes directly from this work: it identifies artificial EM fields as primary interferers with the biological semiconducting system.

The BrainCode® bioenergetic test detects changes in the electrodynamic field before they appear as symptoms — exactly the pre-symptomatic level Burr documented for 44 years.

The BrainCode® Protocol acts on the Living Matrix: every correction introduced by paravertebral neuromodulation spreads through the entire semiconducting connective network.

BrainCode® paravertebral neuromodulation acts directly on the vertebral chains that Tennant identifies as recharging circuits. The goal is to restore the −50 mV potential needed for healing.

BrainCode® works on the electrome — the body's overall bioelectric signature. Correcting field interference means reprogramming the bioelectric code that organises physiology.

The BrainCode® bioenergetic test identifies which external oscillator has altered cellular resonance. The Protocol reintroduces the correct resonance frequency to restore oscillatory coherence.

BrainCode® phase correction acts directly on biophotonic coherence: it introduces the signal in counter-phase to the interference, removing the disturbance that degraded the quality of the cells' biological light.

BrainCode® output vials are the physical carrier of the imprinting: water that structures itself as EZ water around the frequency signature amplified 1000× by the Integrated Device. Pollack's EZ water is the physical substrate that makes the whole protocol possible.

Preparata and Del Giudice's QED provides the precise physical mechanism of BrainCode® imprinting: water's coherence domains capture and retain the amplified frequency signature. It is the academic explanation of why the vials work.

The BrainCode® Integrated Device uses the same principle as Citro's TFF: the frequency signature of a substance, amplified 1000× and transferred to the water in the vials, produces biological effects equivalent to the substance itself.

The BrainCode® Protocol is a negentropic intervention in Schrödinger's sense: it removes the interference that introduced disorder into the field and restores the ordered state the biological system already knows.

The BrainCode® bioenergetic test identifies interference in the informational field McTaggart describes. Every frequency vector works at this level — correcting the disturbance before it turns into biochemical disease.

BrainCode® frequency vectors act on morphic resonance disturbed by interference. The bioenergetic test reads the resonance state of the morphogenetic field — Sheldrake provides the theoretical framework that supports it.

Faggin provides the strongest epistemological justification for the BrainCode® approach: working on the informational-conscious level is not a metaphor — it means working on the causally primary level that organises biology.

Clark's database is the working source of the frequency vectors in the Infections category. Each BrainCode® vector replicates the specific electromagnetic signature of the pathogen — fungus, bacterium, virus or parasite.

Allegretti documents the physical mechanism of frequency amplification and imprinting. The BrainCode® Integrated Device belongs to this technical tradition, with 1000× amplification as its distinguishing feature.

BICOM's 83% clinical success rate across 935 patients treated with phase correction is the most direct clinical evidence for the BrainCode® principle. The difference is the carrier: an external EM signal versus paravertebral neuromodulation.

BrainCode® shares BioSET's core clinical premise: sensitivities are correctable field incompatibilities. The carrier is more powerful: 1000×-amplified phase correction instead of surface acupressure.

Walsh's biochemical profiles correspond directly to the Toxicity and Hormones/Neurotransmitters categories of the BrainCode® frequency vectors. Walsh's 30,000 patients provide the epidemiological basis for these categories.

The amino acids Bianchi describes are the molecular substrates that prepare the nervous system to respond to BrainCode® paravertebral neuromodulation. Without these precursors, the system lacks the building blocks to respond to the signal.

NAET clinically validated that frequency incompatibilities can be corrected without avoidance. BrainCode® uses the same premise with 1000×-amplified phase correction — a more precise and powerful carrier than acupressure.

The Emotional Stress category among the BrainCode® frequency vectors is not a metaphor — it is molecular biology. Pert documents that emotions have a substrate of measurable neuropeptides: their interference has a real frequency signature.

The BrainCode® Protocol can break the epigenetic cycle Restian describes: paravertebral phase correction removes the interfering signal that keeps gene-expression dysregulation active.

Gheorghiu's organ-specific biophotonic coherence explains why the BrainCode® bioenergetic test can identify not only the interfering agent but also the organ bearing its consequences — every organ has a unique biophotonic signature.

Proietti provides the complete anatomical and molecular map of the field BrainCode® works on: the methylation cycle as the pathway of interferences, and the PVS as the physical substrate of the meridians where the Integrated Device introduces the corrective signal.

Spaggiari and Tribbia provide institutional backing for the BrainCode® mechanism: the Adey window explains why weak signals at the right frequency produce maximum effects — exactly the principle behind BrainCode® vials.